摘要
脂质过氧化物酶体增殖物激活受体(PPAR)属于核受体家族。PPARγ配体通过PPARγ依赖或PPARγ不依赖的途径,在调节肠道炎症中起重要作用,有可能成为炎症性肠病的新治疗靶点。其作用机制尚不完全明确,报道较少。
Peroxisome proliferators acteivated receptors(PPAR) are members of nuclear receptor family. Ligand of PPARγ can modulate inflammation of colon through PPARγ dependent or independent way, PPARγ can be a new therapeutic target in inflammatory bowel diseases. The mechanisms of the therapy are not completely clear.
出处
《国际消化病杂志》
CAS
2008年第4期270-272,共3页
International Journal of Digestive Diseases